Bloomberg the Company & Products

Bloomberg Anywhere Login

Bloomberg

Connecting decision makers to a dynamic network of information, people and ideas, Bloomberg quickly and accurately delivers business and financial information, news and insight around the world.

Company

Financial Products

Enterprise Products

Media

Customer Support

  • Americas

    +1 212 318 2000

  • Europe, Middle East, & Africa

    +44 20 7330 7500

  • Asia Pacific

    +65 6212 1000

Communications

Industry Products

Media Services

Follow Us


Last €67.13 EUR
Change Today -0.026 / -0.04%
Volume 4.2K
As of 12:52 PM 04/24/15 All times are local (Market data is delayed by at least 15 minutes).

Financial Statements for astrazeneca plc (ZEG)

Although debt as a percent of total capital increased at AstraZeneca PLC over the last fiscal year to 35.61%, it is still in-line with the Pharmaceuticals industry's norm. Additionally, even though there are not enough liquid assets to satisfy current obligations, Operating Profits are more than adequate to service the debt. Accounts Receivable are typical for the industry, with 71.87 days worth of sales outstanding. Last, inventories seem to be well managed as the Inventory Processing Period is typical for the industry, at 123.12 days.
Currency in
Millions of US Dollars
As of:Dec 31
2011
Restated
Dec 31
2012
Restated
Dec 31
2013
Dec 31
2014
4 Year
Trend
Assets    
Cash and Equivalents7,571.07,701.09,217.06,360.0
Short-Term Investments3,927.046.015.020.0
Trading Asset Securities25.029.046.0--
TOTAL CASH AND SHORT TERM INVESTMENTS11,523.07,776.09,278.06,380.0
Accounts Receivable6,630.05,696.05,514.04,762.0
Other Receivables2,293.01,638.01,288.01,401.0
TOTAL RECEIVABLES8,923.07,334.06,802.06,163.0
Inventory1,852.02,061.01,909.01,960.0
Prepaid Expenses887.01,098.01,571.01,398.0
Other Current Assets321.0779.0775.0796.0
TOTAL CURRENT ASSETS23,506.019,048.020,335.016,697.0
Gross Property Plant and Equipment15,310.015,071.014,907.013,744.0
Accumulated Depreciation-8,885.0-8,982.0-9,089.0-7,734.0
NET PROPERTY PLANT AND EQUIPMENT6,425.06,089.05,818.06,010.0
Goodwill9,862.09,898.09,981.011,550.0
Long-Term Investments201.0199.0281.0561.0
Deferred Tax Assets, Long Term1,514.01,111.01,205.01,219.0
Other Intangibles10,980.016,448.016,047.020,981.0
Other Long-Term Assets342.0741.02,232.01,577.0
TOTAL ASSETS52,830.053,534.055,899.058,595.0
    
LIABILITIES & EQUITY    
Accounts Payable2,155.02,449.02,499.03,492.0
Accrued Expenses6,102.05,917.06,666.06,962.0
Short-Term Borrowings221.0879.0992.01,486.0
Current Portion of Long-Term Debt/Capital Lease1,778.025.0798.0981.0
Current Portion of Capital Lease Obligations--22.030.048.0
Current Income Taxes Payable3,390.02,862.03,076.02,354.0
Other Current Liabilities, Total2,106.01,771.02,020.02,055.0
TOTAL CURRENT LIABILITIES15,752.013,903.016,051.017,330.0
Long-Term Debt7,338.09,347.08,517.08,337.0
Capital Leases--62.072.060.0
Minority Interest226.0215.029.019.0
Pension & Other Post-Retirement Benefits2,680.02,271.02,261.02,951.0
Deferred Tax Liability Non-Current2,735.02,576.02,827.01,796.0
Other Non-Current Liabilities859.01,429.02,918.08,475.0
TOTAL LIABILITIES29,364.029,588.032,646.038,949.0
Common Stock323.0312.0315.0316.0
Additional Paid in Capital3,078.03,504.03,983.04,261.0
Retained Earnings16,128.016,054.015,178.012,539.0
Comprehensive Income and Other3,711.03,861.03,748.02,511.0
TOTAL COMMON EQUITY23,240.023,731.023,224.019,627.0
TOTAL EQUITY23,466.023,946.023,253.019,646.0
TOTAL LIABILITIES AND EQUITY52,830.053,534.055,899.058,595.0
 

Stock Quotes

Market data is delayed at least 15 minutes.

Company Lookup
Recently Viewed
ZEG:GR €67.13 EUR -0.026

ZEG Competitors

Market data is delayed at least 15 minutes.

Company Last Change
AbbVie Inc $66.07 USD +1.82
BASF SE €91.67 EUR +0.86
Biogen Inc $401.71 USD -28.57
Celgene Corp $118.71 USD +2.62
Eli Lilly & Co $71.58 USD -0.82
View Industry Companies
 

Industry Analysis

ZEG

Industry Average

Valuation ZEG Industry Range
Price/Earnings 71.3x
Price/Sales 3.5x
Price/Book 5.4x
Price/Cash Flow 71.3x
TEV/Sales 3.5x
 | 

Sponsored Financial Commentaries

Sponsored Links

Report Data Issue

To contact ASTRAZENECA PLC, please visit . Company data is provided by Capital IQ. Please use this form to report any data issues.

Please enter your information in the following field(s):
Update Needed*

All data changes require verification from public sources. Please include the correct value or values and a source where we can verify.

Your requested update has been submitted

Our data partners will research the update request and update the information on this page if necessary. Research and follow-up could take several weeks. If you have questions, you can contact them at bwwebmaster@businessweek.com.